The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).
D000700:Analgesics / Q000494:pharmacology*; D001519:Behavior / Q000187:drug effects*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D004336:Drug Antagonism; D005663:Furans / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007659:Ketones / Q000008:administration & dosage / Q000494:pharmacology*; D007977:Levallorphan / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology*; D009269:Nalorphine / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010616:Phenanthrenes / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D011581:Psychological Tests / Q000187:drug effects; D011680:Pupil / Q000187:drug effects; D013375:Substance Withdrawal Syndrome
D000700:Analgesics; D001952:Bridged-Ring Compounds; D005663:Furans; D007659:Ketones; D009292:Narcotic Antagonists; D010616:Phenanthrenes; D010919:Placebos; D007977:Levallorphan; D009020:Morphine; D009269:Nalorphine